Procyclidine

Procyclidine
Procyclidine
Systematic (IUPAC) name
1-cyclohexyl-1-phenyl-3-pyrrolidin-1-yl-propan-1-ol hydrochloride
Clinical data
AHFS/Drugs.com monograph
MedlinePlus a605037
Pregnancy cat.  ?
Legal status  ?
Routes oral, im, iv
Pharmacokinetic data
Protein binding ~100%-albumin
Half-life ~12 h
Identifiers
CAS number 77-37-2
77-37-2 (free base)
ATC code N04AA04
PubChem CID 207841
DrugBank APRD00383
ChemSpider 4750
UNII C6QE1Q1TKR YesY
ChEMBL CHEMBL1761 YesY
Chemical data
Formula C19H30ClNO 
Mol. mass 323.9 g/mol
 YesY(what is this?)  (verify)

Procyclidine is an anticholinergic drug principally used for the treatment of:

Contents

Uses

It is used in patients with parkinsonism and akathisia and to reduce the side effects of antipsychotic treatment given for schizophrenia. Procyclidine is also a second-line drug for the treatment of Parkinson's disease. It improves tremor but not rigidity or bradykinesia.

Procyclidine is also sometimes used for the treatment of dystonia (but not tardive dyskinesia), a rare disorder that causes abnormal muscle contraction, resulting in twisting postures of limbs, trunk, or face.

Overdose

Signs of procyclidine overdose are those of an anticholinergic and include confusion, agitation and sleeplessness that can last up to or more than 24 hours. Pupils become dilated and unreactive to light. Tachycardia (fast heart beat), as well as auditory and visual hallucinations have also been reported.

Other known symptoms of overdose are: clumsiness or unsteadiness, being severely drowsy, having a severely dry mouth, nose, or throat, having an altered mood or other mental changes, seizures, being short of breath or having troubled breathing, a dry and warm, flushed skin.

A suspected overdose with severe life-threatening symptoms should immediately be brought to medical attention, where reversal can be attempted with physostigmine administered intravenously or subcutaneously.

Chemistry

Procyclidine, 1-cyclohexyl-1-phenyl-3-pyrrolidinopropan-1-ol, is synthesized in the exact same manner as was seen for trihexyphenidyl, except this time the linear synthesis begins with the preparation of 3-(1-pyrrolidino)propiophenone.

  • E. Jassmann, H. Pfanz, DE 1084734  (1960).
  • E.M. Boffort, U.S. Patent 2,826,590 (1958).
  • D.W. Adamson, P.A. Barrett, S. Wilkinson, J. Chem. Soc., 52(1951).

References